Close Menu

NEW YORK (GenomeWeb) – South Korea's Macrogen announced recently that it received Good Clinical Laboratory Practice accreditation from that country's Ministry of Food and Drug Safety (MFDS.)

GCLP is a quality standard for labs that analyze blood and urine sample for clinical trials, Macrogen said. The designation will enable the firm to perform next-generation sequencing analyses on clinical trial samples. The firm said in a statement that it is the first and only lab in South Korea that is able to work with NGS on such samples.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Dec
02
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Dec
10
Sponsored by
Congenica II

This webinar will discuss the use of next-generation sequencing and an optimized variant interpretation workflow to increase diagnostic yield in complex clinical cases.